Genetic Variant SCL2A2 Is Associated with Risk of Cardiovascular Disease – Assessing the Individual and Cumulative Effect of 46 Type 2 Diabetes Related Genetic Variants

• Anders Borglykke ,

  * E-mail: anders.borglykke@regionh.dk

  Affiliation Research Centre for Prevention and Health, Glostrup University Hospital, Glostrup, Denmark

  ⨯
• Niels Grarup,

  Affiliation The Novo Nordisk Foundation Centre for Basic Metabolic Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Thomas Sparsø,

  Affiliation The Novo Nordisk Foundation Centre for Basic Metabolic Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Allan Linneberg,

  Affiliation Research Centre for Prevention and Health, Glostrup University Hospital, Glostrup, Denmark

  ⨯
• Mogens Fenger,

  Affiliation University Hospital of Copenhagen, Hvidovre, Denmark

  ⨯
• Jørgen Jeppesen,

  Affiliations Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark, Department of Medicine, Glostrup University Hospital, Glostrup, Denmark

  ⨯
• Torben Hansen,

  Affiliations The Novo Nordisk Foundation Centre for Basic Metabolic Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark

  ⨯
• Oluf Pedersen,

  Affiliations The Novo Nordisk Foundation Centre for Basic Metabolic Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark, Hagedorn Research Institute, Gentofte, Denmark, Faculty of Health Sciences, University of Aarhus, Aarhus, Denmark

  ⨯
• Torben Jørgensen

  Affiliations Research Centre for Prevention and Health, Glostrup University Hospital, Glostrup, Denmark, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark, Medical Faculty, University of Aalborg, Aalborg, Denmark

  ⨯